Search - tctmd.com

Displaying 1 - 20 of 148

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

Presenter: Sahil Parikh

October 30, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

Presentation TCT 2024

Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare?

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

News Daily News

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

L.A. McKeown

July 24, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

Presentation Fellows 2024

Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know

Presenter: Sahil A. Parikh

April 14, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

Presentation CTO 2024

An Endovascular Approach to CTO Recanalization

Presenter: Sahil A. Parikh

February 03, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

Presentation TCT 2023

LIFE-BTK: The Top Line Results and Beyond

Presenter: Sahil Parikh

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Top Endovascular News of 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare?

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients

FDA Approves Bioresorbable Scaffold for BTK Lesions

Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

An Endovascular Approach to CTO Recanalization

Top Endovascular News of 2023

LIFE-BTK: The Top Line Results and Beyond

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content